Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34,374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis.
Liu Y, Wang W, Yin R, Zhang Y, Zhang Y, Zhang K, Pan H, Wang K, Lou G, Li G, Zhang R, Li K, Rao J, Zhang B, Wang Y, Wang Q, Gao Y, Li H. Liu Y, et al. Among authors: zhang r, zhang b, zhang k, zhang y. BMC Med. 2023 Sep 29;21(1):376. doi: 10.1186/s12916-023-03046-8. BMC Med. 2023. PMID: 37775744 Free PMC article. Clinical Trial.
Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer.
Liu X, Ran R, Shao B, Rugo HS, Yang Y, Hu Z, Wei Z, Wan F, Kong W, Song G, Jiang H, Liang X, Zhang R, Yan Y, Xu G, Li H. Liu X, et al. Among authors: zhang r. Chin J Cancer Res. 2018 Jun;30(3):315-326. doi: 10.21147/j.issn.1000-9604.2018.03.04. Chin J Cancer Res. 2018. PMID: 30046226 Free PMC article.
[The role of prophylactic use of pegylated recombinant human granulocyte colony-stimulating factor(PEG-rhG-CSF) in breast cancer receiving adjuvant chemotherapy].
Zhang JY, Liu YX, Wang H, Mi L, Song GH, Jiang HF, Yan Y, Shao B, Kong WY, Zhang RY, Ran R, Liu XR, Wang J, Lin YT, Li HP. Zhang JY, et al. Among authors: zhang ry. Zhonghua Yi Xue Za Zhi. 2018 Sep 11;98(34):2718-2721. doi: 10.3760/cma.j.issn.0376-2491.2018.34.008. Zhonghua Yi Xue Za Zhi. 2018. PMID: 30220167 Chinese.
Methylome Variation Predicts Exemestane Resistance in Advanced ER+ Breast Cancer.
Liu XR, Zhang RY, Gong H, Rugo HS, Chen LB, Fu Y, Che JW, Tie J, Shao B, Wan FL, Kong WY, Song GH, Jiang HF, Xu GB, Li HP. Liu XR, et al. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033819896331. doi: 10.1177/1533033819896331. Technol Cancer Res Treat. 2020. PMID: 32129154 Free PMC article.
34,374 results
You have reached the last available page of results. Please see the User Guide for more information.